A Study of 1592U89 in HIV-Infected Adults

Study to Evaluate Safety and Pharmacokinetics of UB-421 Antibody in HIV-1 Infected Adults

NCT01140126 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults

NCT04871113 ·Status: COMPLETED ·Phase: PHASE2

A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VEU 009)

NCT00001021 ·Status: COMPLETED ·Phase: PHASE1

Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection

NCT00002441 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption

NCT01069809 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV

NCT05085145 ·Status: UNKNOWN ·Phase: PHASE4

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex

NCT00002004 ·Status: COMPLETED ·Phase: PHASE1

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

NCT00001041 ·Status: COMPLETED ·Phase: PHASE1

Proof of Principle Study of Pulse Dosing of IL-15 to Deplete the Reservoir in HIV Infected People

NCT02191098 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda

NCT01549470 ·Status: COMPLETED ·Phase: PHASE1

Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection

NCT02591420 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection

NCT00002092 ·Status: COMPLETED ·Phase: NA

Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda

NCT01549509 ·Status: COMPLETED ·Phase: PHASE1

Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)

NCT02411539 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection

NCT05043129 ·Status: UNKNOWN

A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells

NCT00000822 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults

NCT00119873 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption

NCT04340596 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Selection of a Protective T Cell-based HIV-1/FIV Vaccine

NCT02389595 ·Status: ACTIVE_NOT_RECRUITING

Safety and Immunogenicity Study of Three Candidate HIV-1 Vaccines, Administered in Combination to Healthy HIV-1 Uninfected Adults

NCT01151319 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults

NCT01155037 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers

NCT00083330 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons

NCT00996970 ·Status: COMPLETED

Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients

NCT00872417 ·Status: UNKNOWN ·Phase: PHASE4

Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients

NCT01546818 ·Status: COMPLETED ·Phase: PHASE1